Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
Applications | ELISA, FC, IHC |
Reactivities | Human |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
Applications | ELISA, FC, IHC |
Reactivities | Human |
Recombinant Anti-FOXP4 (Clone RAB-S40)
Applications | ELISA, FC, IF |
Reactivities | Human |
Recombinant Anti-FOXP1 (Clone RAB-S37)
Applications | ELISA, FC, IF |
Reactivities | Human |
Recombinant Anti-EGFR (Clone 2F8 (Zalutumumab; HuMax-EGFR))
Applications | ELISA, FC, WB |
Reactivities | Human |
Recombinant Anti-EGFR domain III (Clone h-R3 (Nimotuzumab))
Applications | Bl, FC, IHC |
Reactivities | Human |
Recombinant Anti-CD22 (Clone hL22 (Epratuzumab))
Applications | Bl, FC, IP |
Reactivities | Human, Monkey |
Anti-NKp46 [Bab281], Human IgG1, kappa
Applications | FC, IF, IP |
Reactivities | Human, Macaque |
Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
Applications | Bl, FC |
Reactivities | Human |
Recombinant Anti-CD33 (Clone hP67.6 (Gemtuzumab))
Applications | FC, IF |
Reactivities | Human |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Recombinant Anti-PD-L1 (Clone 332M7)
Applications | Bl, FC |
Reactivities | Human, Mouse, Monkey |